HST Global Inc (HSTC) financial statements (2021 and earlier)

Company profile

Business Address 150 RESEARCH DR.
HAMPTON, VA 23666
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 2 0000
Cash and cash equivalents 2 0000
Total current assets: 2 0000
Noncurrent Assets
TOTAL ASSETS: 2 0000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including: 43525305
Interest and dividends payable  377    
Other undisclosed accounts payable and accrued liabilities 4(373)525305
Debt  3    
Deferred compensation liability   990870750510
Due to related parties 12,988506506506506
Other undisclosed current liabilities  3771,6921,6271,5691,453
Total current liabilities: 53,3713,1933,0282,8552,474
Noncurrent Liabilities
Total liabilities: 53,3713,1933,0282,8552,474
Stockholders' equity
Stockholders' equity attributable to parent, including: (3)(3,371)(3,193)(3,028)(2,854)(2,474)
Common stock 43737373737
Additional paid in capital 5,3582,3852,3852,3852,3852,385
Accumulated deficit (5,366)(5,792)(5,614)(5,449)(5,276) 
Other undisclosed stockholders' equity attributable to parent      (4,896)
Total stockholders' equity: (3)(3,371)(3,193)(3,028)(2,854)(2,474)
TOTAL LIABILITIES AND EQUITY: 2 0000

Income statement (P&L) ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2013
Operating expenses (152)(143)(153)(137)(160)(157)
Other operating income, net
(Other Expenses)
     3635
Other undisclosed operating loss     (36)(35)
Operating loss: (152)(143)(153)(137)(160)(157)
Nonoperating income (expense) 578(36)    
Interest and debt expense 5963612(36)(36)35
Income (loss) from continuing operations before income taxes: 1,023(143)(141)(173)(196)(122)
Income tax expense (benefit) (90)3756 67 
Income (loss) before gain (loss) on sale of properties: 933(105)(85)(173)(129)(122)
Other undisclosed net loss (506)(73)    
Net income (loss): 427(178)(85)(173)(129)(122)
Other undisclosed net loss attributable to parent   (80) (67)(71)
Net income (loss) available to common stockholders, diluted: 427(178)(165)(173)(196)(193)

Comprehensive Income ($ in thousands)

9/30/2020
TTM
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2013
Net income (loss): 427(178)(85)(173)(129)(122)
Comprehensive income (loss), net of tax, attributable to parent: 427(178)(85)(173)(129)(122)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: